Adit EdTech Acquisition ROE 2021-2024 | ADEX
Current and historical return on equity (ROE) values for Adit EdTech Acquisition (ADEX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Adit EdTech Acquisition ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $-0.01B | $-0.06B | 34.21% |
| 2023-12-31 | $-0.02B | $-0.06B | 68.57% |
| 2023-09-30 | $-0.08B | $-0.02B | 234.59% |
| 2023-06-30 | $-0.08B | $-0.02B | 235.11% |
| 2023-03-31 | $-0.07B | $-0.01B | 226.36% |
| 2022-12-31 | $-0.06B | $-0.09B | 186.26% |
| 2022-09-30 | $0.00B | $-0.01B | -20.00% |
| 2022-06-30 | $0.00B | $-0.01B | -14.55% |
| 2022-03-31 | $-0.00B | $-0.02B | 10.81% |
| 2021-12-31 | $-0.00B | $-0.02B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.048B | $0.020B |
| Adit EdTech Acquisition Corp. entered into a definitive merger agreement with Griid Infrastructure LLC. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.152B | 15.70 |
| Cencora (COR) | United States | $45.190B | 17.62 |
| ICON (ICLR) | Ireland | $26.796B | 25.30 |
| DiDi Global (DIDIY) | China | $22.261B | 0.00 |
| Avantor (AVTR) | United States | $16.357B | 24.08 |
| CochLear (CHEOY) | Australia | $14.085B | 0.00 |
| Revvity (RVTY) | United States | $13.482B | 23.65 |
| Natera (NTRA) | United States | $13.082B | 0.00 |
| Viatris (VTRS) | United States | $12.621B | 3.77 |
| Medpace Holdings (MEDP) | United States | $11.970B | 39.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.469B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.737B | 20.56 |
| Solventum (SOLV) | United States | $10.249B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.864B | 0.00 |
| HealthEquity (HQY) | United States | $7.107B | 52.36 |
| Organon (OGN) | United States | $5.485B | 5.20 |
| Bausch + Lomb (BLCO) | Canada | $5.392B | 21.61 |
| Doximity (DOCS) | United States | $5.142B | 36.01 |
| PACS (PACS) | United States | $4.565B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.508B | 32.09 |
| Life Times (LTH) | United States | $3.336B | 34.96 |
| Sotera Health (SHC) | United States | $3.165B | 15.53 |
| GoodRx Holdings (GDRX) | United States | $2.953B | 112.43 |
| Agilon Health (AGL) | United States | $2.591B | 0.00 |
| Progyny (PGNY) | United States | $2.566B | 44.18 |
| NovoCure (NVCR) | Jersey | $2.369B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.126B | 8.42 |
| Premier (PINC) | United States | $1.983B | 8.48 |
| BrightSpring Health Services (BTSG) | United States | $1.927B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.906B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.437B | 0.00 | |
| Embecta (EMBC) | United States | $0.713B | 4.85 |
| CareDx (CDNA) | United States | $0.678B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.650B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.615B | 6.53 |
| InnovAge Holding (INNV) | United States | $0.604B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.512B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.505B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 45.95 |
| ModivCare (MODV) | United States | $0.388B | 7.27 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.349B | 0.00 |
| MultiPlan (MPLN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.298B | 16.28 |
| Sharecare (SHCR) | United States | $0.295B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.228B | 0.00 |
| Biodesix (BDSX) | United States | $0.164B | 0.00 |
| So-Young (SY) | China | $0.105B | 53.00 |
| Pono Capital Two (PTWO) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.67 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| Oncology Institute (TOI) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |